180 related articles for article (PubMed ID: 15660916)
1. Increased mitochondrial respiratory chain enzyme activities correlate with minor extent of liver damage in mice suffering from erythropoietic protoporphyria.
Navarro S; Del Hoyo P; Campos Y; Abitbol M; Morán-Jiménez MJ; García-Bravo M; Ochoa P; Grau M; Montagutelli X; Frank J; Garesse R; Arenas J; de Salamanca RE; Fontanellas A
Exp Dermatol; 2005 Jan; 14(1):26-33. PubMed ID: 15660916
[TBL] [Abstract][Full Text] [Related]
2. A mouse model provides evidence that genetic background modulates anemia and liver injury in erythropoietic protoporphyria.
Abitbol M; Bernex F; Puy H; Jouault H; Deybach JC; Guénet JL; Montagutelli X
Am J Physiol Gastrointest Liver Physiol; 2005 Jun; 288(6):G1208-16. PubMed ID: 15677551
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor ligands in murine models for erythropoietic protoporphyria: potential novel players in the progression of liver injury.
Berasain C; Sampedro A; Mauleón I; Goñi S; Latasa MU; Matscheko N; García-Bravo M; Unzu C; Corrales FJ; Enríquez de Salamanca R; Prieto J; Avila MA; Fontanellas A
Cell Mol Biol (Noisy-le-grand); 2009 Feb; 55(1):29-37. PubMed ID: 19267999
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of fecal fat excretion and the disposal of protoporphyrin in a murine model for erythropoietic protoporphyria.
Gooijert KE; Havinga R; Oosterloo-Duinkerken AR; Venekamp-Hoolsema EE; Kuipers F; Verkade HJ
Am J Physiol Gastrointest Liver Physiol; 2007 Aug; 293(2):G510-6. PubMed ID: 17600043
[TBL] [Abstract][Full Text] [Related]
5. Reversion of hepatobiliary alterations By bone marrow transplantation in a murine model of erythropoietic protoporphyria.
Fontanellas A; Mazurier F; Landry M; Taine L; Morel C; Larou M; Daniel JY; Montagutelli X; de Salamanca RE; de Verneuil H
Hepatology; 2000 Jul; 32(1):73-81. PubMed ID: 10869291
[TBL] [Abstract][Full Text] [Related]
6. Hepatic gene expression in protoporphyic Fech mice is associated with cholestatic injury but not a marked depletion of the heme regulatory pool.
Davies R; Schuurman A; Barker CR; Clothier B; Chernova T; Higginson FM; Judah DJ; Dinsdale D; Edwards RE; Greaves P; Gant TW; Smith AG
Am J Pathol; 2005 Apr; 166(4):1041-53. PubMed ID: 15793285
[TBL] [Abstract][Full Text] [Related]
7. Liver pathology and hepatocarcinogenesis in a long-term mouse model of erythropoietic protoporphyria.
Libbrecht L; Meerman L; Kuipers F; Roskams T; Desmet V; Jansen P
J Pathol; 2003 Feb; 199(2):191-200. PubMed ID: 12533832
[TBL] [Abstract][Full Text] [Related]
8. Biochemical abnormality in erythropoietic protoporphyria: cause and consequences.
Bloomer JR; Wang Y; Singhal A; Risheg H
J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S36-40. PubMed ID: 16819399
[TBL] [Abstract][Full Text] [Related]
9. Prevention of murine erythropoietic protoporphyria-associated skin photosensitivity and liver disease by dermal and hepatic ferrochelatase.
Pawliuk R; Tighe R; Wise RJ; Mathews-Roth MM; Leboulch P
J Invest Dermatol; 2005 Jan; 124(1):256-62. PubMed ID: 15654982
[TBL] [Abstract][Full Text] [Related]
10. Modeling the ferrochelatase c.315-48C modifier mutation for erythropoietic protoporphyria (EPP) in mice.
Barman-Aksözen J; C Wiek P; Bansode VB; Koentgen F; Trüb J; Pelczar P; Cinelli P; Schneider-Yin X; Schümperli D; Minder EI
Dis Model Mech; 2017 Mar; 10(3):225-233. PubMed ID: 28093505
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow-derived cells promote liver regeneration in mice with erythropoietic protoporphyria.
García-Bravo M; Morán-Jiménez MJ; Quintana-Bustamante O; Méndez M; Gutiérrez-Vera I; Bueren J; Salido E; Segovia JC; Fontanellas A; de Salamanca RE
Transplantation; 2009 Dec; 88(12):1332-40. PubMed ID: 20029329
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietic protoporphyria in the house mouse. A recessive inherited ferrochelatase deficiency with anemia, photosensitivity, and liver disease.
Tutois S; Montagutelli X; Da Silva V; Jouault H; Rouyer-Fessard P; Leroy-Viard K; Guénet JL; Nordmann Y; Beuzard Y; Deybach JC
J Clin Invest; 1991 Nov; 88(5):1730-6. PubMed ID: 1939658
[TBL] [Abstract][Full Text] [Related]
13. Cholestyramine resin for erythropoietic protoporphyria with severe hepatic disease: a case report.
Yoo DJ; Lee HC; Yu E; Jin YJ; Shim JH; Kim KM; Lim YS; Chung YH; Lee YS; Suh DJ
Korean J Hepatol; 2010 Mar; 16(1):83-8. PubMed ID: 20375647
[TBL] [Abstract][Full Text] [Related]
14. Neonatal bone marrow transplantation prevents liver disease in a murine model of erythropoietic protoporphyria.
Duchartre Y; Petit N; Moya C; Lalanne M; Dubus P; Verneuil Hd; Moreau-Gaudry F; Richard E
J Hepatol; 2011 Jul; 55(1):162-70. PubMed ID: 21145811
[TBL] [Abstract][Full Text] [Related]
15. The essential role of the transporter ABCG2 in the pathophysiology of erythropoietic protoporphyria.
Wang P; Sachar M; Lu J; Shehu AI; Zhu J; Chen J; Liu K; Anderson KE; Xie W; Gonzalez FJ; Klaassen CD; Ma X
Sci Adv; 2019 Sep; 5(9):eaaw6127. PubMed ID: 31555729
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietic protoporphyria. An overview with emphasis on the liver.
Meerman L
Scand J Gastroenterol Suppl; 2000; (232):79-85. PubMed ID: 11232498
[TBL] [Abstract][Full Text] [Related]
17. Protoporphyrin retention in hepatocytes and Kupffer cells prevents sclerosing cholangitis in erythropoietic protoporphyria mouse model.
Lyoumi S; Abitbol M; Rainteau D; Karim Z; Bernex F; Oustric V; Millot S; Lettéron P; Heming N; Guillmot L; Montagutelli X; Berdeaux G; Gouya L; Poupon R; Deybach JC; Beaumont C; Puy H
Gastroenterology; 2011 Oct; 141(4):1509-19, 1519.e1-3. PubMed ID: 21762662
[TBL] [Abstract][Full Text] [Related]
18. Clinical, biochemical, and genetic study of 11 patients with erythropoietic protoporphyria including one with homozygous disease.
Herrero C; To-Figueras J; Badenas C; Méndez M; Serrano P; Enríquez-Salamanca R; Lecha M
Arch Dermatol; 2007 Sep; 143(9):1125-9. PubMed ID: 17875872
[TBL] [Abstract][Full Text] [Related]
19. Successful therapeutic effect in a mouse model of erythropoietic protoporphyria by partial genetic correction and fluorescence-based selection of hematopoietic cells.
Fontanellas A; Mendez M; Mazurier F; Cario-André M; Navarro S; Ged C; Taine L; Géronimi F; Richard E; Moreau-Gaudry F; Enriquez De Salamanca R; de Verneuil H
Gene Ther; 2001 Apr; 8(8):618-26. PubMed ID: 11320408
[TBL] [Abstract][Full Text] [Related]
20. Ursodesoxycholic acid and heme-arginate are unable to improve hematopoiesis and liver injury in an erythropoietic protoporphyria mouse model.
Abitbol M; Puy H; Sabaté JM; Guénet JL; Deybach JC; Montagutelli X
Physiol Res; 2006; 55 Suppl 2():S93-101. PubMed ID: 17298226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
